Home›People›Kumar Srinivasan
Kumar Srinivasan

Kumar Srinivasan

President & Chief Executive Officer, director at Allotera Therapeutics. Also a director at Pulmotect.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Jul 23, 2026·Suggest an edit

About Kumar Srinivasan

Kumar Srinivasan is a president & chief executive officer, director at Allotera Therapeutics.

Form D filings also name Kumar Srinivasan as a director at Pulmotect.

Kumar Srinivasan first appears on SEC filings in 2020.

Experience

This experience comes from Kumar Srinivasan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kumar Srinivasan in the role, so the role may have started earlier or lasted longer.

Allotera Therapeutics, Inc. Current
President & Chief Executive Officer, director
2023 – Present · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
Aurigene Discovery Technologies Current
Member Board of Directors
2022 – Present
Transcenta
Member Board of Directors
2022 – 2026
Pulmotect, Inc.
Member Board Of Directors
2019 – 2024 · Houston, TX
Turning Point Therapeutics
Executive Vice President & CBO
2021 – 2022
BioPharmaceuticals R&D, AstraZeneca
Vice President, Global Head of Business Development & Licensing
2019 – 2021
AstraZeneca
Vice President
2012 – 2021
Entasis Therapeutics
Member Board of Directors
2015 – 2016
Probiodrug
Chief Business Officer
2010 – 2012
Pfizer
Vice President
2009 – 2010
Wyeth Pharmaceuticals
Vice President
2005 – 2009
Neurogenetics, Inc
VP, Corporate Development
2001 – 2005
TorreyPines Therapeutics
Vice President, Corporate Development
2001 – 2005
Sibia Neurosciences
Principal Research Scientist
1995 – 1999

Key Colleagues at Startups

The people Kumar Srinivasan works with at each company, as listed on that company's latest Form D.

Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
KL
Kevin Li
Director
NM
ND
Matthew Cooper
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
Cherry Thomas
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Pulmotect, Inc. · Form D, Sep 9, 2024
MH
Magnus Hook
Director
CB
Colin Broom
Executive officer and director
BG
Bruce Given
Director
LL
Leo Linbeck
Director
BS

Sources

  1. SECAllotera Therapeutics, Inc. Form D/A, filed Jul 23, 2026
  2. SECPulmotect, Inc. Form D, filed Sep 9, 2024